When the right (Drug) should be left: Prenatal drug exposure and heterotaxy syndrome.

BACKGROUND Recent studies reported an association between prenatal propylthiouracil exposure and birth defects, including abnormal arrangement across the left-right body axis, suggesting an association with heterotaxy syndrome. METHODS This case-control and case-finding study used data from 1981 to 2013 from the EUROCAT birth defect registry in the Northern Netherlands. First, we explored prenatal exposures in heterotaxy syndrome (cases) and Down syndrome (controls). Second, we describe the specific birth defects in offspring of mothers using propylthiouracil (PTU) prenatally. RESULTS A total of 66 cases with heterotaxy syndrome (incidence 12.1 per 100,000 pregnancies) and 783 controls with Down syndrome (143.3 per 100,000 pregnancies) were studied. No differences in intoxication use during pregnancy were found between cases and controls, including smoking (28.0% vs. 22.7%; p = 0.40), alcohol (14.0% vs. 26.9%; p = 0.052), and recreational drugs (0 vs. 0.3%; p = 1.00). We found an association between heterotaxy syndrome and prenatal drug exposure to follitropin-alfa (5.6% vs. 1.1%; p = 0.04), and drugs used in nicotine dependence (3.7% vs. 0.2%; p = 0.02). Five mothers used PTU during pregnancy and gave birth to a child with trisomy 18, renal abnormalities, or hypospadias and cardiac defects. CONCLUSION This study identified follitropin-alfa and drugs used in nicotine dependence as possible teratogens of heterotaxy syndrome. Our data suggest the possibility that there is an increased risk of birth defects (including renal, urological, and cardiac abnormalities) in children born among mothers taking PTU prenatally, but not for heterotaxy syndrome. Birth Defects Research (Part A) 106:573-579, 2016. © 2016 Wiley Periodicals, Inc.

[1]  Na Zhu,et al.  Congenital Anomalies in Children Exposed to Antithyroid Drugs In-Utero: A Meta-Analysis of Cohort Studies , 2015, PloS one.

[2]  W. Evans,et al.  Heterotaxy in Southern Nevada: Prenatal Detection and Epidemiology , 2015, Pediatric Cardiology.

[3]  T. Abdulla,et al.  An overview of cardiac morphogenesis. , 2013, Archives of cardiovascular diseases.

[4]  P. Laurberg,et al.  Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. , 2013, The Journal of clinical endocrinology and metabolism.

[5]  S. Rivkees,et al.  Embryonic exposure to propylthiouracil disrupts left‐right patterning in Xenopus embryos , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  N. Lelong,et al.  Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study , 2012, Heart.

[7]  S. Rasmussen,et al.  Survival among people with Down syndrome: a nationwide population-based study in Denmark , 2012, Genetics in Medicine.

[8]  R. Lowry,et al.  Congenital heart defect case ascertainment by the Alberta Congenital Anomalies Surveillance System. , 2012, Birth defects research. Part A, Clinical and molecular teratology.

[9]  S. Rivkees,et al.  Propylthiouracil Is Teratogenic in Murine Embryos , 2012, PloS one.

[10]  Robert H. Anderson,et al.  Population-based evaluation of a suggested anatomic and clinical classification of congenital heart defects based on the International Paediatric and Congenital Cardiac Code , 2011, Orphanet journal of rare diseases.

[11]  S. Gilboa,et al.  Maternal Smoking and Congenital Heart Defects in the Baltimore-Washington Infant Study , 2011, Pediatrics.

[12]  M. Clementi,et al.  Treatment of hyperthyroidism in pregnancy and birth defects. , 2010, The Journal of clinical endocrinology and metabolism.

[13]  Guido Cocchi,et al.  International trends of Down syndrome 1993-2004: Births in relation to maternal age and terminations of pregnancies. , 2010, Birth defects research. Part A, Clinical and molecular teratology.

[14]  G. Visser,et al.  Congenital Heart Disease in Pregnancies Complicated by Maternal Diabetes Mellitus , 2009, Herz.

[15]  S. Ware,et al.  Disorders of left–right asymmetry: Heterotaxy and situs inversus , 2009, American journal of medical genetics. Part C, Seminars in medical genetics.

[16]  Franck Sturtz,et al.  The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome , 2009, Genetics in Medicine.

[17]  Matthew J Strickland,et al.  Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. , 2008, The Journal of pediatrics.

[18]  Robert H. Anderson,et al.  The nomenclature, definition and classification of cardiac structures in the setting of heterotaxy , 2007, Cardiology in the Young.

[19]  Robert H. Anderson,et al.  Controversies, genetics, diagnostic assessment, and outcomes relating to the heterotaxy syndrome , 2007, Cardiology in the Young.

[20]  P. D. del Nido,et al.  Improving results of the modified Fontan operation in patients with heterotaxy syndrome. , 2002, The Annals of thoracic surgery.

[21]  C. Loffredo,et al.  Risk factors for heart disease associated with abnormal sidedness. , 2002, Teratology.

[22]  J. Olsen,et al.  Recall Bias in a Case-Control Surveillance System on the Use of Medicine during Pregnancy , 2001, Epidemiology.

[23]  Erika Varga,et al.  Description and mission evaluation of the Hungarian case-control surveillance of congenital abnormalities, 1980-1996. , 2001, Teratology.

[24]  L. Holmes,et al.  Heterotaxy: Associated conditions and hospital-based prevalence in newborns , 2000, Genetics in Medicine.

[25]  S. Wasiak,et al.  Retinoic acid affects left-right patterning. , 1999, Developmental biology.

[26]  N. Talner,et al.  Report of the New England Regional Infant Cardiac Program, by Donald C. Fyler, MD, Pediatrics, 1980;65(suppl):375-461. , 1998, Pediatrics.

[27]  K. Kosaki,et al.  Genetics of human left-right axis malformations. , 1998, Seminars in cell & developmental biology.

[28]  F. R. Sinatra,et al.  Biliary atresia, intestinal malrotation, partial abdominal heterotaxia, and craniofacial anomalies in a newborn with intrauterine opiate exposure. , 1994, Journal of pediatric gastroenterology and nutrition.

[29]  S. Antonarakis,et al.  Mitotic errors in somatic cells cause trisomy 21 in about 4.5% of cases and are not associated with advanced maternal age , 1993, Nature Genetics.

[30]  S. Zaffran,et al.  Genetics and embryological mechanisms of congenital heart diseases. , 2009, Archives of cardiovascular diseases.